Dragon's blood is a traditional Chinese medicine with a long history, which has the effects of promoting blood circulation and removing blood stasis, stopping bleeding and relieving pain, and healing sores and promoting muscle growth. Modern research shows that dragon's blood mainly contains chemical components such as phenols, terpenoids, steroids and steroidal saponins, styrenees, lignans, alkaloids, polysaccharides, and volatile oils. Pharmacological research reveals that it has extensive effects such as promoting skin wound healing, anti-inflammatory and analgesic effect, anti-platelet aggregation and anti-thrombosis, cardiovascular protection, antibacterial effect, neuroprotection, radiation protection, anti-tumor effect, regulating metabolism, and antiviral effect. By summarizing the research reports on the chemical components and pharmacological effects of dragon's blood at home and abroad in recent years, this paper provides references for the in-depth exploration of the medicinal value of dragon's blood and the development of related products.

1.韦浩明, 蓝日春, 滕红丽, 主编. 中国壮药材[M]. 南宁: 广西民族出版社, 2016: 392-393.

2.黄岑汉, 覃道光, 窦锡彬, 等, 主编. 民族医药与方剂学[M]. 南宁: 广西科学技术出版社, 2016: 158-159.

3.陈明岭, 江海燕, 著. 皮肤病常用中药药理及临床. 第2版[M]. 北京: 中国技术出版社, 2017: 338.

4.陈品秋, 班玮康, 王文艳, 等. 龙血竭及其主要活性成分对脑缺血的药理作用与机制研究进展[J]. 中草药, 2023, 54(18): 6172-6184. [Chen PQ, Ban WK, Wang WY, et al. Research progress of pharmacological effects and mechanism of Resina draconis and its active constituents on cerebral ischemia[J]. Chinese Traditional and Herbal Drugs, 2023, 54(18): 6172-6184.] DOI: 10.7501/j.issn.0253-2670.2023.18.034.

5.林忆龙, 文亦磊, 黄洪, 等. 龙血竭化学成分及药理作用研究进展[J]. 中国民族民间医药, 2020, 29(6): 50-55. [Lin YL, Wen  YL, Huang H, et al. Research progress on the chemical components and pharmacological effects of Resina draconis[J]. Chinese Journal of Ethnomedicine and Ethnopharmacy, 2020, 29(6): 50-55.] DOI: 10.3969/j.issn.1007-8517.2020.6.zgmzmjyyzz202006014.

6.Liu Y, Zhao X, Yao R, et al. Dragon's blood from dracaena worldwide: species, traditional uses, phytochemistry and pharmacology[J]. Am J Chin Med, 2021, 49(6): 1315-1367. DOI: 10.1142/S0192415X21500634.

7.周瑶, 李伟, 曲欣楠, 等. 天然二氢查尔酮类化合物分布及生物活性研究进展[J]. 中国野生植物资源, 2014, 33(6): 36-40, 46. [Zhou Y, Li W, Qu XN, et al. Review on the Distribution and biological activity of dihydrochalcone[J]. Chinese Wild Plant Resources, 2014, 33(6): 36-40, 46.] DOI: 10.3969/j.issn.1006- 9690.2014.06.009.

8.郑庆安, 陈江弢, 张颖君, 等. 著名民间药物血竭的化学成分与生理活性[J]. 天然产物研究与开发, 2005, 17(B06): 84-95. [Zheng QA, Chen JT, Zhang YJ, et al. The chemical components and physiological activities of the well-known folk medicine Xuejie[J]. Natural Product Research and Development, 2005, 17(B06): 84-95.] https://www.nstl.gov.cn/paper_detail.html?id=e1f676a7afdc9337aff6b663406f7362.

9.郑庆安. 龙血竭研究[D]. 昆明: 中国科学院昆明植物研究所, 2003. DOI: http://ir.kib.ac.cn:8080/handle/151853/690.

10.周志宏, 陈江弢, 王锦亮, 等. 云南血竭中的酚性成分（2）（摘要）[J]. 药学实践杂志, 2000, (5): 354. [Zhou ZH, Chen JT, Wang  JL, et al. Phenolic components in yunnan blood (2) (abstract) [J]. Journal of Pharmaceutical Practice, 2000, (5): 354.] DOI: 1006-0111(2000)05-0354-1A.

11.张丽, 王绪平, 黄孝闻, 等. 血竭及龙血竭化学成分、药理作用研究进展[J]. 中国现代应用药学, 2019, 36(20): 2605-2611. [Zhang L, Wang XP, Huang XW, et al. Advance of the chemical components and pharmacological effects of Draconis sanguis and Resina draconis[J]. Chinese Journal of Modern Applied Pharmacy, 2019, 36(20): 2605-2611.] DOI: 10.13748/j.cnki.issn1007-7693.2019.20.025.

12.卢文杰, 王雪芬, 陈家源. 剑叶龙血树氯仿部位化学成分的研究[J]. 药学学报, 1998, 33(10): 755-758. [Lu WJ, Wang XF, Chen  JY. Research on the chemical composition of chloroform parts of leaves of Dracaena cochinchinensis[J]. Acta Pharmaceutica Sinica, 1998, 33(10): 755-758.] DOI: 10.16438/j.0513-4870.1998.10.007.

13.张兴锋, 朱功俊, 龚韦凡, 等. 龙血竭黄酮类成分研究[J]. 广州化工, 2020, 48(9): 92-95. [Zhang XF, Zhu GJ, Gong WF, et al. Study on flavonoids in Resina draconis[J]. Guangzhou Chemical Industry, 2020, 48(9): 92-95. DOI: 10.3969/j.issn.1001-9677.2020.09.032.

14.潘利峰, 董乃维, 吴立军. 查耳酮类化合物的活性及其合成研究进展[J]. 沈阳药科大学学, 2018, 35(6): 509-516. [Pan  LF, Dong NW, Wu LJ. Study progress on biological activities and synthesis of chalcone derivatives[J]. Journal of Shenyang Pharmaceutical University, 2018, 35(6): 509-516.] DOI: 10.14066/j.cnki.cn21-1349/r.2018.06.012.

15.杨敏, 杨瑞, 覃彬华, 等. 民族药龙血竭研究进展[J]. 海峡药学, 2019, 31(11): 49-52. [Yang M, Yang R, Qin BH, et al. Research progress of the ethnic medicine dragon's blood[J]. Strait Pharmacy, 2019, 31(11): 49-52.] DOI: 10.3969/j.issn.1006-3765. 2019.11.013.

16.刘芳, 戴荣继, 邓玉林, 等. 龙血竭化学成分研究进展[J]. 中国药房, 2010, 21: 1437-1439. [Liu F, Dai RJ, Deng YL, et al. Research progress on the chemical components of dragon's blood[J]. China Pharmacy, 2010, 21: 1437-1439.] DOI: 1001-0408(2010)15-1437-03.

17.邹立军, 邵宜锐, 熊霞, 等. 黄酮类化合物调控断奶仔猪肠黏膜屏障功能的研究进展[J]. 中国科学: 生命科学, 2025, 55(1): 30-44. [Zou LJ, Shao YR, Xiong X, et al. Current advances on the regulation of intestinal mucosal barrier function in weaned piglets by flavonoids[J]. Science in China(Series C), 2025, 55(1): 30-44.] DOI: 10.1360/SSV-2023-0264.

18.Benny AT, Arikkatt SD, Vazhappilly CG, et al. Chromone, a privileged scaffold in drug discovery: developments in the synthesis and bioactivity[J]. Mini Rev Med Chem, 2022, 22(7): 1030-1063. DOI: 10.2174/1389557521666211124141859.

19.Weng CJ, Yen GC. Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives[J]. Cancer Treat Rev, 2012, 38(1): 76-87. DOI: 10.1016/j.ctrv.2011.03.001.

20.Jiang JS, Gu QC, Feng ZM, et al. The phenolic acids from the plant of Salvia miltiorrhiza[J]. Fitoterapia, 2022, 159: 105180. DOI: 10.1016/j.fitote.2022.105180.

21.高文远, 主编. 中药生物工程[M]. 上海: 上海科学技术出版社, 2023: 5.

22.常景玲, 主编. 天然生物活性物质及其制备技术[M]. 郑州: 河南技术出版社, 2007: 85.

23.张荣平, 王兴红, 主编. 圣药龙血竭[M]. 昆明: 云南科技出版社, 2012: 6.

24.周长林, 编. 微生物学与免疫学[M]. 南京: 东南大学出版社, 2013: 360.

25.Teka T, Zhang L, Ge X, et al. Stilbenes: source plants, chemistry, biosynthesis, pharmacology, application and problems related to their clinical application-a comprehensive review[J]. Phytochemistry, 2022, 197: 113128. DOI: 10.1016/j.phytochem.2022.113128.

26.Xu J, Xiong T, Yang Y, et al. Resina draconis as a topical treatment for pressure ulcers: a systematic review and Meta-analysis[J]. Wound Repair Regen, 2015, 23(4): 565-574. DOI: 10.1111/wrr.12314.

27.Sun S, Wang P, Yue K, et al. Effect and mechanism of dragon's blood on wound healing of patients with stress hand injury[J]. Evid Based Complement Alternat Med, 2023, 2023: 6122331. DOI: 10.1155/2023/6122331.

28.Liu H, Lin S, Xiao D, et al. Evaluation of the wound healing potential of resina draconis (Dracaena cochinchinensis) in animal models[J]. Evid Based Complement Alternat Med, 2013, 2013: 709865. DOI: 10.1155/2013/709865.

29.李丹, 惠瑞, 胡咏武, 等. 血竭提取物对成纤维细胞增殖及合成透明质酸的影响[J]. 中华整形外科杂志, 2015, 31(1): 53-57. [Li D, Hui R, Hu YW, et al. Effects of extracts of dragon's blood on fibroblast proliferation and extracellular matrix hyaluronic acid[J]. Chinese Journal of Plastic Surgery, 2015, 31(1): 53-57.] DOI: 10.3760/cma.j.issn.1009-4598.2015.01.015.

30.He TC, Wang DW, Zheng SM, et al. Antifungal and wound healing promotive compounds from the resins of Dracaena cochinchinensis[J]. Fitoterapia, 2021, 151: 104904. DOI: 10.1016/j.fitote.2021.104904.

31.Xiong Z, Huo M, Jia Y, et al. Dracorhodin perchlorate regulates the expression of inflammatory cytokines through the TLR4 pathway and improves skin wound healing in diabetic rats[J]. Evid Based Complement Alternat Med, 2022, 2022: 9050686. DOI: 10.1155/2022/9050686.

32.Liu X, Chen S, Zhang Y, et al. Modulation of dragon's blood on tetrodotoxin-resistant sodium currents in dorsal root ganglion neurons and identification of its material basis for efficacy[J]. Sci China C Life Sci, 2006, 49(3): 274-285. DOI: 10.1007/s11427-006-0274-4.

33.Wang ST, Chen S, Guo M, et al. Inhibitory effect of cochinchinenin B on capsaicin-activated responses in rat dorsal root ganglion neurons[J]. Brain Res, 2008, 1201: 34-40. DOI: 10.1016/j.brainres.2007.12.068.

34.Li YS, Wang JX, Jia MM, et al. Dragon's blood inhibits chronic inflammatory and neuropathic pain responses by blocking the synthesis and release of substance P in rats[J]. J Pharmacol Sci, 2012, 118(1): 43-54. DOI: 10.1254/jphs.11160fp.

35.Wan Y, Yu Y, Pan X, et al. Inhibition on acid-sensing ion channels and analgesic activities of flavonoids isolated from dragon's blood resin[J]. Phytother Res, 2019, 33(3): 718-727. DOI: 10.1002/ptr.6262.

36.Xu J, Liu J, Li Q, et al. Pterostilbene participates in TLR4-mediated inflammatory response and autophagy-dependent Aβ1-42 endocytosis in Alzheimer's disease[J]. Phytomedicine, 2023, 119: 155011. DOI: 10.1016/j.phymed.2023.155011.

37.Lin Y, Xiong W, Xiao S, et al. Pharmacoproteomics reveals the mechanism of Chinese dragon's blood in regulating the RSK/TSC2/mTOR/ribosome pathway in alleviation of DSS-induced acute ulcerative colitis[J]. J Ethnopharmacol, 2020, 263: 113221. DOI: 10.1016/j.jep.2020.113221.

38.Lin Y, Xiong W, Xiao S, et al. Pharmacoproteomics reveals the mechanism of Chinese dragon's blood in regulating the RSK/TSC2/mTOR/ribosome pathway in alleviation of DSS-induced acute ulcerative colitis[J]. J Ethnopharmacol, 2020, 263: 113221. DOI: 10.1016/j.jep.2020.113221.

39.王艳红, 叶明福, 刘帆. 血竭提取物对牙龈炎大鼠牙周组织修复及TLR4/NF-κB信号通路的影响[J]. 上海口腔医学, 2022, 31(6): 602-606. [Wang YH, Ye MF, Liu F. The effect of blood exhaustion extract on periodontal tissue repair and TLR4/NF-κB signaling pathway in rats with gingivitis[J]. Shanghai Journal of Stomatology, 2022, 31(6): 602-606.] DOI: 10.19439/j.sjos.2022.06.007.

40.Liu Y, Mo L, Lu H, et al. Dragon blood resin ameliorates steroid-induced osteonecrosis of femoral head through osteoclastic pathways[J]. Front Cell Dev Biol, 2023, 11: 1202888. DOI: 10.1002/kjm2.12426.

41.Zhu Y, Zhang P, Yu H, et al. Anti-Helicobacter pylori and thrombin inhibitory components from Chinese dragon's blood, Dracaena cochinchinensis[J]. J Nat Prod, 2007, 70(10): 1570-1577. DOI: 10.1021/np070260v.

42.Xin N, Li YJ, Li Y, et al. Dragon's Blood extract has antithrombotic properties, affecting platelet aggregation functions and anticoagulation activities[J]. J Ethnopharmacol, 2011, 135(2): 510-514. DOI: 10.1016/j.jep.2011.03.063.

43.Hao HZ, He AD, Wang DC, et al. Antiplatelet activity of loureirin A by attenuating Akt phosphorylation: in vitro studies[J]. Eur J Pharmacol, 2015, 746: 63-69. DOI: 10.1016/j.ejphar.2014.10.059.

44.Jiang Y, Zhang G, Yan D, et al. Bioactivity-guided fractionation of the traditional Chinese medicine resina draconis reveals loureirin B as a PAI-1 inhibitor[J]. Evid Based Complement Alternat Med, 2017, 2017: 9425963. DOI: 10.1155/2017/9425963.

45.Liang J, Mei S, Qiao X, et al. A botanical medicine dragon's blood exhibited clinical antithrombosis efficacy similar to low molecular weight heparin[J]. Sci China Life Sci, 2021, 64(10): 1691-1701. DOI: 10.1007/s11427-020-1848-8.

46.Qi Y, Gu H, Song Y, et al. Metabolomics study of resina draconis on myocardial ischemia rats using ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry combined with pattern recognition methods and metabolic pathway analysis[J]. Evid Based Complement Alternat Med, 2013, 2013: 438680. DOI: 10.1155/2013/438680.

47.Su X, Xue H, Lou Y, et al. Investigation of the potential mechanism of compound dragon's blood capsule against myocardial ischemiabased on network pharmacology[J]. Comb Chem High Throughput Screen, 2024, 27(19): 2940-2950. DOI: 10.2174/0113862073264485240102064653.

48.Li C, Zhang Y, Wang Q, et al. Dragon's blood exerts cardio-protection against myocardial injury through PI3K-AKT-mTOR signaling pathway in acute myocardial infarction mice model[J]. J Ethnopharmacol, 2018, 227: 279-289. DOI: 10.1016/j.jep.2018.09.010.

49.Yang TR, Zhang T, Mu NH, et al. Resina draconis inhibits the endoplasmic-reticulum-induced apoptosis of myocardial cells via regulating miR-423-3p/ERK signaling pathway in a tree shrew myocardial ischemia-reperfusion model[J]. J Biosci, 2019, 44(2): 53. DOI: 10.1007/s12038-019-9872-8.

50.Zheng J, Liu B,Lun Q, et al. Longxuetongluo capsule inhibits atherosclerosis progression in high-fat diet-induced ApoE-/-mice by improving endothelial dysfunction[J]. Atherosclerosis, 2016, 255: 156-163. DOI: 10.1016/j.atherosclerosis.2016.08.022.

51.Luo Y, Wang H, Zhao YX, et al. Cytotoxic and antibacterial flavonoids from dragon's blood of Dracaena cambodiana[J]. Planta Med, 2011, 77(18): 2053-2056. DOI: 10.1055/s-0031-1280086.

52.Zhu Y, Zhang P, Yu H, et al. Anti-Helicobacter pylori and thrombin inhibitory components from Chinese dragon's blood, Dracaena cochinchinensis[J]. J Nat Prod, 2007, 70(10): 1570-1577. DOI: 10.1021/np070260v.

53.Irani M, Abadi PG, Ahmadian-Attari MM, et al. In vitro and in vivo studies of dragon's blood plant (D. Cinnabari)-loaded electrospun chitosan/PCL nanofibers: cytotoxicity, antibacterial, and wound healing activities[J]. Int J Biol Macromol, 2024, 257(Pt  1): 128634. DOI: 10.1016/j.ijbiomac.2023.128634.

54.Wang H, Jiang HM, Li FX, et al. Flavonoids from artificially induced dragon's blood of Dracaena cambodiana[J]. Fitoterapia, 2017, 121: 1-5. DOI: 10.1016/j.fitote.2017.06.019.

55.Zheng X, Chen L, Zeng W, et al. Antibacterial and anti-biofilm efficacy of chinese dragon's blood against staphylococcus aureus isolated from infected wounds[J]. Front Microbiol, 2021, 12: 672943. DOI: 10.3389/fmicb.2021.672943.

56.He TC, Wang DW, Zheng SM, et al. Antifungal and wound healing promotive compounds from the resins of Dracaena cochinchinensis[J]. Fitoterapia, 2021, 151: 104904. DOI: 10.1016/j.fitote.2021.104904.

57.Liu Y, Mi Y, Wang Y, et al. Loureirin C inhibits ferroptosis after cerebral ischemia reperfusion through regulation of the Nrf2 pathway in mice[J]. Phytomedicine, 2023, 113: 154729. DOI: 10.1016/j.phymed.2023.154729.

58.Ren J, Zhang X, Zhou L, et al. Comprehensive evaluation of dragon's blood in combination with borneol in ameliorating ischemic/reperfusion brain injury using RNA sequencing, metabolomics, and 16S rRNA sequencing[J]. Front Pharmacol, 2024, 15: 1372449. DOI: 10.3389/fphar.2024.1372449.

59.Jiang M, Su X, Liu J, et al. Systems pharmacology-dissection of the molecular mechanisms of dragon's blood in improving ischemic stroke prognosis[J]. Evid Based Complement Alternat Med, 2020, 2020: 4858201. DOI: 10.1155/2020/4858201.

60.Xu J, Liu J, Li Q, et al. Loureirin C ameliorates ischemia and reperfusion injury in rats by inhibiting the activation of the TLR4/NF-κB pathway and promoting TLR4 degradation[J]. Phytother Res, 2022, 36(12): 4527-4541. DOI: 10.1002/ptr.7571.

61.Xu P, Li S, Wu Q, et al. Loureirin C, from Chinese dragon's blood (Dracaena cochinchinensis S.C. Chen), is a novel selective estrogen receptor α modulator with anti-Alzheimer's disease effects[J]. Fitoterapia, 2023, 167: 105497. DOI: 10.1016/j.fitote.2023.105497.

62.Kunisawa K, Shan J, Lu Q, et al. Loureirin c and xanthoceraside attenuate depression-like behaviors and expression of interleukin-17 in the prefrontal cortex induced by chronic unpredictable mild stress in mice[J]. Neurochem Res, 2022, 47(9): 2880-2889. DOI: 10.1007/s11064-022-03692-z.

63.Yang Y, Mouri A, Lu Q, et al. Loureirin c and xanthoceraside prevent abnormal behaviors associated with downregulation of brain derived neurotrophic factor and AKT/mTOR/CREB Signaling in the prefrontal cortex induced by chronic corticosterone exposure in mice[J]. Neurochem Res, 2022, 47(9): 2865-2879. DOI: 10.1007/s11064-022-03694-x.

64.Xin N, Li YJ, Li X, et al. Dragon's blood may have radioprotective effects in radiation-induced rat brain injury[J]. Radiat Res, 2012, 178(1): 75-85. DOI: 10.1667/rr2739.1.

65.Ran Y, Wang R, Hasan M, et al. Radioprotective effects of dragon's blood and its extracts on radiation-induced myelosuppressive mice[J]. J Ethnopharmacol, 2014, 154(3): 624-634. DOI: 10.1016/j.jep.2014.04.036.

66.Ran Y, Wang R, Gao Q, et al. Dragon's blood and its extracts attenuate radiation-induced oxidative stress in mice[J]. J Radiat Res, 2014, 55(4): 699-706. DOI: 10.1093/jrr/rru013.

67.Ran Y, Xu B, Wang R, et al. Dragon's blood extracts reduce radiation-induced peripheral blood injury and protects human megakaryocyte cells from GM-CSF withdraw-induced apoptosis[J]. Phys Med, 2016, 32(1): 84-93. DOI: 10.1016/j.ejmp.2015.09.010.

68.田颖颖, 杨爱琳, 陈孝男, 等. 龙血竭抗肿瘤作用研究进展 [J]. 中国中药杂志, 2021, 46(8): 2037-2044. [Tian YY, Yang AL, Chen  XN, et al. Research progress on anti-tumor effect of Chinese dragon's blood[J]. China Journal of Chinese Materia Medica, 2021, 46(8): 2037-2044. DOI: 10.19540/j.cnki.cjcmm.20201215.601.

69.Park MN, Jeon HW, Rahman MA, et al. Daemonorops draco blume induces apoptosis against acute myeloid leukemia cells via regulation of the miR-216b/c-Jun[J]. Front Oncol, 2022, 12: 808174. DOI: 10.3389/fonc.2022.808174.

70.Chen X, Zhao Y, Yang A, et al. Chinese dragon's blood etoac extract inhibits liver cancer growth through downregulation of smad3[J]. Front Pharmacol, 2020, 11: 669. DOI: 10.3389/fphar.2020.00669.

71.Ouyang L, Li J, Chen X, et al. Chinese dragon's blood ethyl acetate extract suppresses gastric cancer progression through induction of apoptosis and autophagy mediated by activation of MAPK and downregulation of the mTOR-Beclin1 signalling cascade[J]. Phytother Res, 2023, 37(2): 689-701. DOI: 10.1002/ptr.7652.

72.Hong Y, Sun X, Lu L. Loureirin B inhibits cervical cancer development by blocking pi3k/akt signaling pathway: network pharmacology analysis and experimental validation[J]. Appl Biochem Biotechnol, 2024, 196(12): 8587-8604. DOI: 10.1007/s12010-024-04975-7.

73.Zhang J, Chang M, Wang X, et al. Pterostilbene targets the molecular oscillator RORγ to restore circadian rhythm oscillation and protect against sleep restriction induced metabolic disorders[J]. Phytomedicine, 2024, 125: 155327. DOI: 10.1016/j.phymed.2023.155327.

74.Gu HJ, Lv JC, Yong KL, et al. Antidiabetic effect of an active fraction extracted from dragon's blood (Dracaena cochinchinensis) [J]. J Enzyme Inhib Med Chem, 2009, 24(1): 136-139. DOI: 10.1080/14756360801936399.

75.Mothana RA, Arbab AH, ElGamal AA, et al. Isolation and characterization of two chalcone derivatives with anti-hepatitis B virus activity from the endemic socotraen Dracaena cinnabari (dragon's blood tree)[J]. Molecules, 2022, 27(3): 952. DOI: 10.3390/molecules27030952.

76.Qi Y, Zheng J, Zi Y, et al. Loureirin C improves mitochondrial function by promoting Nrf2 nuclear translocation to attenuate oxidative damage caused by renal ischemia-reperfusion injury[J]. Int Immunopharmacol, 2024, 138: 112596. DOI: 10.1016/j.intimp.2024.112596.